Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights

Arcus Biosciences (RCUS) Misses Q2 EPS by 21c

August 5, 2021 4:56 PM EDT

Arcus Biosciences (NYSE: RCUS) reported Q2 EPS of ($1.09), $0.21 worse than the analyst estimate of ($0.88). Revenue for the quarter came in at $9.46 million versus the consensus estimate of $13.05 million.

We have made significant progress advancing our portfolio and partnerships in the first half of... More